Navigation Links
Pulmo BioTech Announces Details of the Methodology for its Phase I Human Trials
Date:5/16/2008

ospital and educational facility). Jointly owned by MHI subsidiary Innovacor as the technical and operational partner, Dr. Jocelyn Dupuis (the scientific director and originator of the PulmoBind Molecular Imaging technology), and by Pulmo BioTech Inc. as the funding partner, PulmoScience Inc. aims to develop this unique and exciting technology, to fund necessary trials, and to bring the products to market.

PulmoScience believes that the market for its product candidates is worth in excess of $500 million per annum and that, provided Regulatory Approval is achieved, the safety and efficacy of its products could allow it to dominate that market.

About PulmoBind

PulmoBind uses an intravenously delivered radionuclide tagged molecule which specifically bonds to the inner walls of the circulatory system in the lungs, and by the use of an external Gamma Camera allows an image of the integrity of the blood vessels throughout the lungs to be seen by a diagnostic clinician. PulmoScience is currently undertaking Regulatory Approval for Phase I Human Trials, and while subsequent results from additional tests might not corroborate the current results, PulmoScience believes that PulmoBind has the potential to dominate the market for the diagnosis of Pulmonary Embolism. In particular, this belief is driven by PulmoScience's expectations of the improved safety and efficacy that PulmoBind will offer when compared to the current incumbent nuclear medicine based technology for the diagnosis of Pulmonary Embolism. In addition, early indications are that PulmoBind could be highly effective in the early stage diagnosis of Pulmonary Hypertension, a condition for which there is no current front line diagnostic test.

Forward-Looking Statements

Forward-looking statements contained in this and other written and oral reports are made based on known events and circumstances at the time of release, and as such, are subject in the future to unforeseen uncertaint
'/>"/>

SOURCE Pulmo BioTech Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Terguride Receives FDA Orphan Drug Designation for the Treatment of Pulmonary Arterial Hypertension
2. PulmoBioTech Announces Details of Its Regulatory Approval Experiments
3. Edwards Lifesciences Announces First Implants in U.S. Study of Minimally-Invasive Pulmonic Valve
4. Pediatric Pulmonary Expert Comments on Study of Lung Transplants for Cystic Fibrosis
5. Study Shows Need to Test More COPD and Asthma Patients for Underdiagnosed Pulmonary Disease
6. Results of TRIUMPH-1 Trial of Viveta in Pulmonary Arterial Hypertension to Be Announced Before Market Open on Thursday, November 1, 2007
7. Tracleer(R) Shows Clinical Benefit as Combination Therapy with Sildenafil for Pulmonary Arterial Hypertension
8. Champions Biotechnology and Concordia Pharmaceuticals Complete Service Agreement and Begin Preclinical Evaluation of Oncology Drugs
9. Strykers Biotech Division Receives FDA Warning Letter
10. Lixte Biotechnology Holdings Announces That Anti-Cancer Activity Against Glioblastoma in an Animal Model Was Reported at the Annual Meeting of the American Association of Cancer Research
11. Data From Ortho Biotech-Sponsored Studies to be Presented at National Kidney Foundation 2008 Spring Clinical Meetings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... SOLON, Ohio, Dec. 16 HDT Engineered ... next generation technologies and a principal subcontractor for ... (MPL), led development of new anthropromorphic arm technology ... a prosthetic arm and hand, including a sense ... Defense Advanced Research Projects Agency (DARPA) Revolutionizing Prosthetics ...
(Date:12/16/2009)... 16 A new application ... the clinical review of specialty pharmaceuticals has increased ... drugs reviewed while reducing costs. ,, AIM, a ... with health plan clients representing over 35 million ... (NYSE: WLP ), adapted the successful ...
(Date:12/16/2009)... Dec. 16 EuroPharma, Inc. signs ... the use of super absorbency BCM-95® curcumin ... formulations. The exclusive distribution territory for ... food store channel and professional channel, which ... clinics. BCM-95® is a highly absorbable ...
Breaking Medicine Technology:HDT Develops Robotic Arm Technology for DARPA's Revolutionizing Prosthetics 2009 Program 2American Imaging Management's New Specialty Drug Program Delivers Immediate Results 2American Imaging Management's New Specialty Drug Program Delivers Immediate Results 3American Imaging Management's New Specialty Drug Program Delivers Immediate Results 4EuroPharma Exclusive Distributor of BCM-95 and BosPure 2EuroPharma Exclusive Distributor of BCM-95 and BosPure 3Researcher says microchannels could advance tissue engineering methods 9601 1Researcher says microchannels could advance tissue engineering methods 9601 2Researcher says microchannels could advance tissue engineering methods 9601 3Researcher says microchannels could advance tissue engineering methods 9601 4Wyeth Announces Full Redemption of Floating Rate Convertible Senior Debentures Due 2024 54657 1Wyeth Announces Full Redemption of Floating Rate Convertible Senior Debentures Due 2024 54657 2Wyeth Announces Full Redemption of Floating Rate Convertible Senior Debentures Due 2024 54657 3Wyeth Announces Full Redemption of Floating Rate Convertible Senior Debentures Due 2024 54657 4Chicago Mayor Honors Astellas Excellence in Learning Development 54654 1Chicago Mayor Honors Astellas Excellence in Learning Development 54654 2
... Results Presented at Endocrine Society,s 90th Annual Meeting -, ... Inc. (Nasdaq: BNVI ) today announced results on ... regulation. The data, which,were presented at the Endocrine Society ... activation of GADD45 gene via the estrogen receptor,beta results ...
... Results Presented at Endocrine Society,s 90th Annual Meeting ... 16 ,Bionovo Inc. (Nasdaq: BNVI ) today ... important in developing drugs for breast cancer and,osteoporosis. ... Society,s,90th Annual Meeting, showed that the new regulatory ...
Other Medicine Technology:Bionovo Elucidates Mechanism of Breast Cancer Control by Estrogen Receptor Beta 2Bionovo Elucidates Mechanism of Breast Cancer Control by Estrogen Receptor Beta 3Bionovo Discovers New Estrogen Regulatory Elements for Breast Cancer and Osteoporosis Drugs 2Bionovo Discovers New Estrogen Regulatory Elements for Breast Cancer and Osteoporosis Drugs 3
(Date:12/16/2009)... half, but use in humans is still far off , , ... nature, researchers have built and tested synthetic versions of the ... other cases where blood just won,t stop flowing. , "We ... in degradable stitches, which dissolve in the body," said Erin ... Reserve University, and lead author of a report published ...
(Date:12/16/2009)... Substance Specific Neurological Stress Reduction Therapy or NSRTSM is found ... chronic conditions such as allergies, asthma, migraines, chronic fatigue and ... practices throughout the country are using this holistic therapy including ... ... Minneapolis, MN (Vocus) December 14, 2009 ...
(Date:12/16/2009)... government report finds , , WEDNESDAY, Dec. 16 (HealthDay News) ... 45.4 million Americans of all ages -- or 15.1 ... according to new National Health Interview Survey statistics released ... of all ages had been uninsured for at least ... 31.9 million (10.6 percent) had been uninsured for more ...
(Date:12/16/2009)... -- OrthoAccel Technologies, Inc., developers of the ... to enhance orthodontics, announced Alison Davies as its ... Ms. Davies has spent the last fourteen years ... most recently for nine years as a senior ... Invisalign . ,, (Logo: ...
(Date:12/16/2009)... Calif., Dec. 16 New research ... bioactive compounds in pistachios, and molecules present ... Pistachio oil decreases levels of an inflammatory ... tetratricopeptide repeats 2). Inflammation is a complex ... cells or irritants, and it underlies functional ...
Breaking Medicine News(10 mins):Health News:Synthetic Platelets Put the Brakes on Blood Loss 2Health News:Synthetic Platelets Put the Brakes on Blood Loss 3Health News:BioVeda Health and Wellness Center of Chanhassen, MN Announces Its Grand Opening 2Health News:BioVeda Health and Wellness Center of Chanhassen, MN Announces Its Grand Opening 3Health News:BioVeda Health and Wellness Center of Chanhassen, MN Announces Its Grand Opening 4Health News:BioVeda Health and Wellness Center of Chanhassen, MN Announces Its Grand Opening 5Health News:Over 45 Million Americans Now Lack Health Insurance 2Health News:Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom 2Health News:Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom 3Health News:Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom 4Health News:New Study Reveals Pistachios Have Anti-Inflammatory Properties 2Health News:New Study Reveals Pistachios Have Anti-Inflammatory Properties 3
... medicine may no longer be truly alternative shows ... 34,000 readers. The report revealed that Chiropractic was ... drugs, // by readers with back pain. Deep-tissue ... treating osteoarthritis and fibromyalgia. While readers suffering from ...
... Aliskiren can possibly be the latest method of ... from early studies of aliskiren indicate that the ... for patients with mild-to-moderate uncomplicated // essential high ... trials also suggest that the new medication is ...
... for preventing pregnancies have recently also been under intense ... sexually transmitted diseases (e.g. Gonorrhea and 25 other related ... protection even the most famous lover of all, Casanova ... birth control and for protection against infection. The question ...
... tragedies of our society that persons infected with HIV/AIDS not ... which any person with any illness must do - but ... // . ,Our attitude to the disease rests largely ... campaigns that has been conducted so far. Infact, a hardened ...
... video games and use violent moves such as karate kicks ... study by Kevin Kieffer and Jessica Nicoll of Saint Leo ... up' video games // and how children and adolescents ... online edition of science journal Nature. ,Some researchers had ...
... the available data, the introduction of chicken doctors because ... of hospitalizations and visits to pox // . The ... subject. ,Varicella vaccine is recommended for routine immunization ... older susceptible children and adults in the United States, ...
Other Medicine News:Health News:Aliskiren: A New Treatment For Hypertension 2Health News:"An Armour against pleasure, and a cobweb against infection" – Has the condom withstood the test of time 2Health News:"An Armour against pleasure, and a cobweb against infection" – Has the condom withstood the test of time 3Health News:"An Armour against pleasure, and a cobweb against infection" – Has the condom withstood the test of time 4Health News:Chicken Pox Hospitalizations Are Becoming Less 2
... Store 200 to 350 Liters of pure ... and Distribution of Purified Water,Millipores compact S.D.S. ... store 200 to 350 liters of purified ... and to maintain consistent purity of stored ...
... Millipore has developed a range of ... match specific water quality requirements. Each ... is designed to specifically target contaminants ... HPLC, molecular biology and ICP-MS. The ...
... developed a range of Milli-Q ultrapure ... water quality requirements. Each of the ... to specifically target contaminants detrimental to ... biology and ICP-MS. The systems incorporate ...
... range of Milli-Q ultrapure water systems ... requirements. Each of the five new ... target contaminants detrimental to particular applications ... ICP-MS. The systems incorporate a high ...
Medicine Products: